SHEMESH SHAY (Chief Development Officer) purchased 0.0% of their position (500.00 shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $3.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/22/2022ACC: 0001104659-22-129348
Officer· Chief Development Officer
Since Feb 2022
+500.00
Net shares
Net buyer
$3.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
500.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+500.00
Price / share
$7.65
Trade value
$3.83K
% of position
0.0%
12/21/2022
1.25M→1.25M
Total
Net shares
+500.00
Net value
$3.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/21/2022 | P · Purchase | +500.00 | $7.65 | $3.83K | 0.0% | 1.25M | 1.25M |
| Total | +500.00 | $3.83K | ||||||
Derivative Transactions0
No derivative transactions reported